Retreatment of Lung Adenocarcinoma Patients With Gefitinib Who Had Experienced Favorable Results From Their Initial Treatment With This Selective Epidermal Growth Factor Receptor Inhibitor: A Report of Three CasesSeiji Yano, Saburo Sone, Emiko Nakataki et al.|Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics|2005Cited by 97
Antitumor Vascular Strategy for Controlling Experimental Metastatic Spread of Human Small-Cell Lung Cancer Cells with ZD6474 in Natural Killer Cell–Depleted Severe Combined Immunodeficient MiceSeiji Yano, Saburo Sone, Emiko Nakataki et al.|Clinical Cancer Research|2005Cited by 48
Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES‐10 cells) highly expressing vascular endothelial growth factor and its receptorEmiko Nakataki, Saburo Sone, Seiji Yano et al.|Cancer Science|2006Cited by 44
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangementHirokazu Ogino, Saburo Sone, Soji Kakiuchi et al.|Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University)|2009Cited by 23
Novel dual targeting strategy with vandetanib induces tumor cell apoptosis and inhibits angiogenesis in malignant pleural mesothelioma cells expressing RET oncogenic rearrangementHirokazu Ogino, Saburo Sone, Seiji Yano et al.|Cancer Letters|2008Cited by 1